NCT02529553View on ClinicalTrials.gov

A Study of LY3076226 in Participants With Advanced or Metastatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

March 28, 2018

Study Completion Date

March 28, 2018

Conditions
Advanced CancerMetastatic Cancer
Interventions
DRUG

LY3076226

Administered IV

Trial Locations (4)

29425

Medical University of South Carolina, Charleston

78229

The START Center for Cancer Care, San Antonio

19111-2497

Fox Chase Cancer Center, Philadelphia

V5Z 4E6

For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician., Vancouver

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02529553 - A Study of LY3076226 in Participants With Advanced or Metastatic Cancer | Biotech Hunter | Biotech Hunter